Global Pediatric Vaccine Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Monovalent, Multivalent), By Technology (Live-attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines, Toxoid Vaccines, Others), By Application (Infectious Diseases, Cancer, Allergies) And By Geography - Forecasts From 2019 To 2024

Published:  May 2021 Report Code: KSI061611923 Pages: 127

The Global Pediatric Vaccine market is expected to reach US$42.865 billion by 2023 from US$21.144 billion in 2017 growing at a CAGR of 12.50%. Vaccination and immunization of children are essential components of modern medicine and may vary slightly depending upon the region, even though many vaccines are common.

These vaccines help protect children from various diseases by helping develop immunity (protection) against diseases before they come into contact with them. Vaccines are started at early age children are at increased risk for infectious diseases because their immune systems have is yet to built up the necessary defenses to fight serious infections and diseases. The growth may be attributed to the rising awareness among people regarding the importance of immunization. An increase in government and non-government funding in research and development of the vaccines will also augment the market growth for pediatric vaccines during the given time frame. However, the high cost of the immunization vaccine may hamper the growth of the market during the given time frame.

This research study examines the current market trends related to demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases, and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global pediatric Vaccine market value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the global pediatric vaccine market.

Major industry players profiled as part of the report are Serum Institute of India Pvt. Ltd., Novartis AG, and GlaxoSmithKline plc among others.

Segmentation

By Type

Monovalent

Multivalent

By Technology

Live-attenuated vaccines

Inactivated vaccines

Subunit, recombinant, polysaccharide, and conjugate vaccines

Toxoid vaccines

Others

By Application

Infectious Diseases

Cancer

Allergies

By Geography

North America

United States

Canada

Others

South America

Brazil

Argentina

Others

Europe

United Kingdom

Germany

France

Others

Middle East and Africa

Saudi Arabia

UAE

Israel

Others

Asia Pacific

China

India

Australia

South Korea

Others

1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
 
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
 
3. Key Findings of the Study
 
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
 
5. Global Pediatric Vaccine Market Forecast by Type 
5.1. Monovalent
5.2. Multivalent
 
6. Global Pediatric Vaccine Market Forecast by Technique
6.1. Live-attenuated vaccines
6.2. Inactivated vaccines
6.3. Subunit, recombinant, polysaccharide, and conjugate vaccines
6.4. Toxoid vaccines
6.5. Others
 
7. Global Pediatric Vaccine Market Forecast by Application
7.1. Infectious Diseases
7.2. Cancer 
7.3. Allergies
 
8. Global Pediatric Vaccine Market Forecast by Geography 
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil 
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific 
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others 
 
9. Competitive intelligence
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
 
10. Company Profiles
10.1. GlaxoSmithKline plc
10.1.1. Overview 
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. Merck Sharp & Dohme Corp.
10.2.1. Overview 
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Sanofi
10.3.1. Overview 
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. Pfizer Inc.
10.4.1. Overview 
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. VBI Vaccines Inc.
10.5.1. Overview 
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Serum Institute of India Pvt. Ltd.
10.6.1. Overview 
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. AstraZeneca
10.7.1. Overview 
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Mitsubishi Tanabe Pharma Corporation
10.8.1. Overview 
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Novartis AG
10.9.1. Overview 
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. Seqirus (CSL Limited)
10.10.1. Overview 
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
 

GlaxoSmithKline Plc

Merck Sharp & Dohme Corp.

Sanofi

Pfizer Inc.

VBI Vaccines Inc.

Serum Institute of India Pvt. Ltd.

AstraZeneca

Mitsubishi Tanabe Pharma Corporation

Novartis AG

Seqirus (CSL Limited)

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us